MSH at World Lung Conference: Stronger Health Systems to Fight TB
MSH is preparing for our largest presence ever at the 47th Union World Conference on Lung Health in Liverpool, United Kingdom, October 26-29, 2016. Events include exclusive sneak peek at "The Lucky Specials," a movie demystifying TB, more than 60 posters and 13 oral presentations, 7 symposiums and workshops, our exhibit hall booth (number 34), and more.
For 45 years, MSH has worked at all levels of the health system—with policymakers, health professionals, and communities—in more than 150 countries to strengthen health systems and improve the quality, availability, and affordability of health services. In response to the HIV and TB epidemics, we build the capacity of our public and private sector partners to prevent TB and HIV and improve diagnosis and management of co-infected patients.
Through collaboration with our country partners and national TB and AIDS control programs in 20 nations throughout Africa, Asia, Europe, Latin America, and the Caribbean, we work to increase access to quality services and medicines. Some of our key interventions include developing policy guidelines to ensure TB and HIV patients receive the care they need, implementing standard operating procedures to guide health service delivery processes, and training and supervising local health workers to improve clinical care and management of patients co-infected with TB and HIV.
Selected events listed below. For a full schedule of MSH events at the conference, follow our conference blog. Join the World Lung 2016 conversation on Twitter with @MSHHealthImpact and #unionconf and #healthsystem.
A First Look and Clips from The Lucky Specials: A Movie Demystifying TB
Special Event | Friday, October 28, 5:30 - 7:00 p.m. | ACC Liverpool, Session Room 1A
How do you connect with the public about tuberculosis in a new way? How do you tell a compelling public health story in a world cluttered with health messages? The MSH-implemented Leadership Management and Governance Project, together with Discovery Learning Alliance, Howard Hughes Medical Institute, and Wellcome Trust, share their innovative initiative "The Lucky Specials"—a feature film aimed at changing how communities and individuals understand and respond to TB.
- Ambassador Deborah L. Birx, MD, U.S. Global AIDS Coordinator & US Special Representative for Global Health Diplomacy
- Catharine Taylor, Vice President, MSH
- Tim Greene, co-writer, Producer, Quizzical Pictures
- Aric Noboa, Producer, President, Discovery Learning Alliance
- Laura Helft, PhD, Senior Science Researcher, HHMI
- Allison Russel, MBBCh, Treatment Advisor, USAID RHAP
Active TB drug safety monitoring and management: a transformative approach to limit treatment-related patient harm
Symposium | Thursday, October 27, 10:30-12:00 | ACC Liverpool, Session Room 8
Reporting adverse events from real-life clinical practice contributes to evidence for decision making that impacts prescribing practices and improves treatment safety. In 2015, the World Health Organization launched the active drug safety monitoring management strategy. The strategy aims to promote the safe use of new TB medicines and novel regimens and develop a robust safety database to proactively protect public health.
- Presenter and Chair: Antonia Kwiecien, MSH
Challenging Tuberculosis in Urban Settings and Big Cities in African, Euro-Asian and Latin American Countries
Symposium | Friday, October 28, 10:30-12:00 | ACC Liverpool, Session Room 4
The world's total urban population reached an estimated 3.8 billion in 2013, and is projected to swell to nearly 6.3 billion by 2050. In 2015, the urban population represented over half of the global population compared to about a third in 1960. During the last two decades, TB incidence has increased in urban settings and big cities as a result of several social and demographic factors, including poor TB control efforts and the rise and concentration of high-risk groups.
- Presenter and Chair: Pedro Suarez, MSH
- Presenter: Mohammad Rashidi, Challenge TB, MSH, Afghanistan
(Addressing the TB control issue in fragile states: urban DOTS experience in Kabul, Afghanistan)
TB elimination initiative in countries of Latin America Region
Symposium | Saturday, October 29, 10:30-12:00 | ACC Liverpool, Session Room 4
There is heterogeneity in the distribution of tuberculosis incidence rates among countries of the Americas, from over 200 cases to less than 10 cases per 100,000 population. A group of low-incidence countries in the Latin America Region was constituted in 2000, including Chile, Costa Rica, Cuba, Uruguay, and Venezuela. In 2010, the US, Canada and Puerto Rico were invited to join. The group aims to adapt TB control measures to these contexts, exchange North-South and South-South experiences, and develop a TB elimination plan aligned with WHO's framework for TB elimination in low-incidence countries
- Presenter and Chair: Pedro G Suarez, MSH